Clinical Trial Update: Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined aribulin with carboplatin and bevacizumab trial in ovarian cancer is in Phase 1/2 with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• aribulin (halichondrin B analog)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN